Raymond James Financial Services Advisors’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-87,029
| Closed | -$349K | – | 3034 |
|
|
2020
Q3 | $349K | Buy |
87,029
+400
| +0.5% | +$1.6K | ﹤0.01% | 2196 |
|
|
2020
Q2 | $398K | Sell |
86,629
-1,925
| -2% | -$8.84K | ﹤0.01% | 2059 |
|
|
2020
Q1 | $289K | Sell |
88,554
-9,070
| -9% | -$29.6K | ﹤0.01% | 1862 |
|
|
2019
Q4 | $421K | Hold |
97,624
| – | – | ﹤0.01% | 2089 |
|
|
2019
Q3 | $384K | Buy |
+97,624
| New | +$384K | ﹤0.01% | 2073 |
|
|
2017
Q3 | – | Sell |
-10,334
| Closed | -$39K | – | 2586 |
|
|
2017
Q2 | $39K | Buy |
+10,334
| New | +$39K | ﹤0.01% | 2409 |
|